3C
SLAB icon

361 Capital’s Silicon Laboratories SLAB Stock Holding History

361 Capital’s Portfolio SLAB Stock Details SLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,148
Closed -$2.04M – 339
2017
Q4 		$2.04M Sell
23,148
-4,015
-15% -$361K 0.51% 108
2017
Q3 		$2.17M Buy
+27,163
New +$2.02M 0.42% 106

Other funds holding SLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

361 Capital's SLAB Position: Q1 2018 in Review

361 Capital sold out of Silicon Laboratories (SLAB) in Q1 2018, closing a stake of 23,148 shares — an estimated $2.04M sold.

361 Capital first reported a position in SLAB in Q3 2017 and held it in 2 quarters. The position peaked at $2.17M in Q3 2017. 253 funds tracked by Wall St. Rank hold SLAB as of Q1 2018.

  • 361 Capital reported no remaining Silicon Laboratories position as of Q1 2018 after selling out during the quarter.
  • 361 Capital sold 23,148 Silicon Laboratories shares in Q1 2018, an estimated $2.04M.
  • 361 Capital first reported a position in Silicon Laboratories in Q3 2017 and held it in 2 quarters.
  • 361 Capital's Silicon Laboratories position peaked at $2.17M in Q3 2017.
  • 253 funds tracked by Wall St. Rank held Silicon Laboratories as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.